New Jersey · 17271

Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm in New Jersey

New Jersey Medicare Avg
$122.93
23% above national avg
National Medicare Avg
$100.30
All states combined
Billed Charge (NJ)
$324.70
What providers submit
Est. Commercial (NJ)
$408.88
National avg: $296.25
Est. Cash / Self-Pay (NJ)
$209.55
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

829
Services in NJ
178
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in New Jersey

Provider Medicare Services
Durham, Booth MD $128.91 47
Rollins, Terry M.D. $132.59 34
Popkin, Mark MD $131.76 33

New Jersey Pricing in Context

In New Jersey, CPT code 17271 (Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm) carries an average Medicare payment of $122.93 — 23% above the national benchmark of $100.30. 178 providers across the state submitted claims for this procedure in 2023, performing 829 total services. Individual payments in NJ ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in New Jersey is $324.70, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New Jersey sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Skin/Integumentary Surgery procedures, the estimated commercial insurance price in New Jersey lands near $408.88, with self-pay cash prices typically around $209.55. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm cost in New Jersey?

The average Medicare payment for Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm in New Jersey is $122.93, which is 23% above the national average of $100.30. Providers in NJ typically bill $324.70 for this procedure.

What does Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm cost with insurance in New Jersey?

With commercial insurance in New Jersey, Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm costs an estimated $408.88. Without insurance, the estimated cash price is $209.55. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm in New Jersey?

178 providers in New Jersey billed Medicare for Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm in 2023, performing 829 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm cheaper in New Jersey than the national average?

No — Destruction Of Cancer Skin Growth Of Scalp, Neck, Hands, Feet, Or Genitals, 0.6-1.0 Cm costs 23% above the national average in New Jersey. The state average Medicare payment is $122.93 compared to $100.30 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial